Literature DB >> 2440557

Reduction in protein tyrosine phosphorylation during differentiation of human leukemia cell line K-562.

J M Richardson, A O Morla, J Y Wang.   

Abstract

Human chronic myelogenous leukemia cell line K-562 expresses the bcr/c-abl fusion protein which is an active protein tyrosine kinase. Multiple tyrosine-phosphorylated proteins were detected in K-562 cells by immunoblotting with a high-affinity anti-phosphotyrosine antibody. When K-562 cells were induced with hemin to progress through the erythroid differentiation pathway, reduction in the levels of these tyrosine-phosphorylated proteins was observed. This reduction in tyrosine-phosphorylated proteins was not found in another chronic myelogenous leukemia cell line which could not be induced to differentiate by hemin. This and other observations established that the reduction in protein tyrosine phosphorylation is a specific differentiation response. The bcr/c-abl protein synthesis was reduced in hemin-treated K-562 cells. Thus, erythroid differentiation of K-562 cells reduces the level of the bcr/c-abl tyrosine kinase and the phosphotyrosine content of its substrate proteins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440557

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.

Authors:  J R McWhirter; J Y Wang
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

2.  Hematopoietic growth factors activate the tyrosine phosphorylation of distinct sets of proteins in interleukin-3-dependent murine cell lines.

Authors:  A O Morla; J Schreurs; A Miyajima; J Y Wang
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

3.  Role of protein kinase C in adriamycin-induced erythroid differentiation of K562 cells.

Authors:  R Hoffman; E S Newlands
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  A 41-kilodalton protein is a potential substrate for the p210bcr-abl protein-tyrosine kinase in chronic myelogenous leukemia cells.

Authors:  E Freed; T Hunter
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

5.  Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.

Authors:  M Wetzler; M Talpaz; R A Van Etten; C Hirsh-Ginsberg; M Beran; R Kurzrock
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

6.  Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican.

Authors:  R Steinfeld; H Van Den Berghe; G David
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

7.  A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins.

Authors:  J R McWhirter; D L Galasso; J Y Wang
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

8.  The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation.

Authors:  M W Renshaw; J R McWhirter; J Y Wang
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

9.  Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential.

Authors:  W M Franz; P Berger; J Y Wang
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

10.  Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context.

Authors:  M W Renshaw; E T Kipreos; M R Albrecht; J Y Wang
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.